Get the Stockscreener App
24.90
2.47%
0.60
After Hours:
24.90
Privia Health Group Inc stock is traded at $24.90, with a volume of 696.52K.
It is up +2.47% in the last 24 hours and up +2.94% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$24.30
Open:
$24.28
24h Volume:
696.52K
Relative Volume:
0.83
Market Cap:
$2.84B
Revenue:
$1.72B
Net Income/Loss:
$12.82M
P/E Ratio:
249.00
EPS:
0.1
Net Cash Flow:
$98.59M
1W Performance:
-0.68%
1M Performance:
+2.94%
6M Performance:
+17.45%
1Y Performance:
+43.35%
1-Day Range:
$23.93
$24.92
1-Week Range:
$23.93
$25.76
52-Week Range:
$15.92
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
24.90 | 2.84B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
241.60 | 38.84B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
58.45 | 11.14B | 550.17M | 201.35M | 232.07M | 1.00 |
|
TEM
Tempus Ai Inc
|
62.60 | 10.17B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.65 | 7.93B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
39.25 | 7.10B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
Investing in Smarter Healthcare: The New Era of AI-Driven Medicine - The Globe and Mail
Top Executives Cash In on Privia Health Group Stock - TipRanks
Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks - Yahoo Finance
How the (PRVA) price action is used to our Advantage - news.stocktradersdaily.com
The Manufacturers Life Insurance Company Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World
Privia Health’s Earnings Call Highlights Growth and Challenges - TipRanks
Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook - TipRanks
Has Privia Health Group, Inc.'s (NASDAQ:PRVA) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Tower Research Capital LLC TRC Sells 799 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance - Investing.com
Privia Health: Q1 Earnings Snapshot - New Haven Register
Privia Health Group Inc (PRVA) Q1 2025 Earnings Call Highlights: Strong Growth and Strategic ... By GuruFocus - Investing.com Canada
Privia Health Reports Strong Q1 2025 Results - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
Privia Health Group: Strong Financial Performance and Strategic Growth Positioning Justify Buy Rating - TipRanks
Privia Health Group Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Privia Health beats Q1 2025 expectations - Investing.com
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Privia Health beats Q1 2025 expectations By Investing.com - Investing.com UK
Privia Health Group, Inc. SEC 10-Q Report - TradingView
Privia Health Group's Q1 Non-GAAP Earnings, Revenue Rise - marketscreener.com
Privia Health (PRVA) Misses Q1 Earnings Estimates - Yahoo Finance
Privia Health beats Q1 estimates, raises full-year outlook By Investing.com - Investing.com Nigeria
Privia Health beats Q1 estimates, raises full-year outlook - Investing.com Australia
Privia Health (NASDAQ:PRVA) Exceeds Q1 Expectations - Yahoo Finance
Privia Health Reports First Quarter 2025 Financial Results - The Manila Times
Earnings Flash (PRVA) Privia Health Group Reports Q1 Revenue $480.1M, vs. FactSet Est of $452.8M - marketscreener.com
Privia Health Reports First Quarter 2025 Financial Results - GlobeNewswire Inc.
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Privia Health (PRVA) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Where are the Opportunities in (PRVA) - news.stocktradersdaily.com
Privia Health Group, Inc. (NASDAQ:PRVA) Short Interest Update - Defense World
Ratio Examination: Privia Health Group Inc (PRVA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
It is Poised to be a Bull Market for Privia Health Group Inc (PRVA) - Sete News
Privia Health Group, Inc. : Beginning of a new cycle - marketscreener.com
Privia Health Group (PRVA) Expected to Announce Earnings on Thursday - Defense World
LPL Financial LLC Buys New Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Is Privia Health Group, Inc.'s (NASDAQ:PRVA) Recent Stock Performance Influenced By Its Financials In Any Way? - Yahoo Finance
Privia Health Group (NASDAQ:PRVA) Receives “Market Outperform” Rating from JMP Securities - Defense World
JMP maintains Market Outperform on Privia Health, $29 target By Investing.com - Investing.com India
JMP maintains Market Outperform on Privia Health, $29 target - Investing.com
Cerity Partners LLC Lowers Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Bank of Montreal Can Boosts Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Legal & General Group Plc Sells 6,612 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Buy” by Analysts - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Stock Holdings Increased by JPMorgan Chase & Co. - Defense World
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):